secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIOMARIN PHARMACEUTICAL INC (BMRN)
CIK:        0001048477
Form:       8-K
Filed at:   2025-12-17T23:59:59+00:00
Accession:  0001193125-25-322704
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

BioMarin appoints Rashmi Ramchandani as Chief Accounting Officer, effective Jan 19, 2026
--------------------------------------------------------------------------------

- Ramchandani becomes VP, Chief Accounting Officer and principal accounting officer; CFO Brian Mueller remains principal financial officer.
- Compensation: $460k base salary, $400k sign-on bonus, 45% target bonus, RSUs valued at $1.05M (4-year vest) and $400k (1-year cliff), options valued at $450k (4-year monthly vest).
- She previously served as VP, Global Business Controller at Gilead Sciences and VP, Controller at Strava. Background includes Deloitte, Clorox, McKesson.
- Sign-on bonus repayable if employment ends within two years for reasons other than job elimination, death, or disability.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1048477/000119312525322704/0001193125-25-322704-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1048477/000119312525322704/d848371d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-322704

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer